- FDA finalizes guidance on psychedelics, plans broader hearingThe FDA has finalized clinical guidance for psychedelic drug developers and has scheduled a public hearing on future therapeutic use, adding regulatory momentum to a class on the precipice of appro…Endpoints · 13d ago↗ source
- FDA proposes rule to simplify drugmakers' factory registrationsThe FDA is proposing a rule to change how factories are registered with the agency if they are making products for the US market, as part of a continuing effort to try to speed up ...Endpoints · 13d ago↗ source
- STAT+: Dementia study replicates promising outcomes following risk-reduction strategiesA dementia prevention trial praised as a "landmark" effort further demonstrated the promise of structured programs tailored to local cultures.